[The treatment of vascular disorders in Alzheimer's disease]

[Article in Russian]

Review

[Article in Russian]

I V Damulin. Zh Nevrol Psikhiatr Im S S Korsakova. 2005.

. 2005;105(12):49-54.

No abstract available

Similar articles

[Current aspects of drug correction of impaired circulation in the ocular vessels].
Kiseleva TN, Polunin GS, Lagutina IuM. Kiseleva TN, et al. Vestn Oftalmol. 2007 Mar-Apr;123(2):37-9. Vestn Oftalmol. 2007. PMID: 17650609 Review. Russian. No abstract available.
Pharmacological treatment in patients with chronic venous disease.
Marinović Kulišić S, Lupi D. Marinović Kulišić S, et al. Acta Dermatovenerol Croat. 2012;20(3):197-200. Acta Dermatovenerol Croat. 2012. PMID: 23069307 Review. No abstract available.
Iloprost in peripheral vascular disease--platelet function and clinical outcome.
Fitscha P, Tiso B, Sinzinger H. Fitscha P, et al. Prog Clin Biol Res. 1987;242:463-8. Prog Clin Biol Res. 1987. PMID: 2444993 Clinical Trial. No abstract available.
Therapeutic use of n-3 fatty acids for vascular disease and thrombosis.
Goodnight SH, Cairns JA. Goodnight SH, et al. Chest. 1995 Oct;108(4 Suppl):302S-304S. doi: 10.1378/chest.108.4_supplement.302s. Chest. 1995. PMID: 7555184 Review. No abstract available.
[Vascular risk factors and Alzheimer's disease].
Regalado Doña PJ, Azpiazu Artigas P, Sánchez Guerra ML, Almenar Monfort C. Regalado Doña PJ, et al. Rev Esp Geriatr Gerontol. 2009 Mar-Apr;44(2):98-105. doi: 10.1016/j.regg.2008.12.004. Epub 2009 Mar 5. Rev Esp Geriatr Gerontol. 2009. PMID: 19268394 Review. Spanish.